Tolerance Bio
Biotechnology company focused on developing therapeutics that induce immune tolerance for the treatment of autoimmune diseases and other immune-mediated conditions.
Location
Philadelphia, Pennsylvania, USA
Categories
biotech, immunology, autoimmune, immune-tolerance
Notes
Tolerance Bio is a biotechnology company focused on developing therapeutics that induce immune tolerance. The company is part of the BioAdvance portfolio, a regional life sciences investment organization based in the Philadelphia area.
Immune tolerance approaches aim to reprogram the immune system to stop attacking self-tissues (in autoimmune diseases) or to accept transplanted organs without the need for lifelong immunosuppression. This represents a potentially transformative approach to treating:
- Autoimmune diseases
- Transplant rejection
- Allergies
- Other immune-mediated conditions
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Part of BioAdvance portfolio
- Immune tolerance focus
- Autoimmune disease applications
- Philadelphia, Pennsylvania area
- Regional life sciences company